Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 97 Results

Title
Intervention Indication Therapeutic Area Year Actions
Durvalumab with Bacillus Calmette-Guerin for treating non-muscle invasive bladder cancer Bacillus Calmette-Guerin (BCG; BCG Tokyo-172; OncoTICE) , Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) Bladder cancer Urological Cancer 2022 View  |  Download
Durvalumab with bevacizumab adjuvant therapy for treating newly diagnosed hepatocellular carcinoma at high risk of recurrence after curative therapy Bevacizumab (Avastin; R 435; RG 405; RG 435) , Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) Hepatocellular carcinoma (HCC) Gastrointestinal Cancer 2022 View  |  Download
Durvalumab with gemcitabine-cisplatin neoadjuvant treatment and durvalumab adjuvant treatment for muscle-invasive bladder cancer Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) Bladder cancer Urological Cancer 2022 View  |  Download
Durvalumab with tremelimumab for limited stage small-cell lung cancer Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) , Tremelimumab (CP-675206; CP-675 206) Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2022 View  |  Download
Duvelisib for treating relapsed and/or refractory peripheral T-cell lymphoma Duvelisib (ABBV-954; INK-1197; IPI-145; Copiktra) Peripheral T-cell lymphoma (PTCL) Haematological Cancer and Lymphomas 2022 View  |  Download
Efanesoctocog alfa for treating and preventing bleeding in people with haemophilia A who have been previously treated Efanesoctocog alfa Haemophilia A Haematology 2022 View  |  Download
Empagliflozin for treating chronic kidney disease Empagliflozin (Jardiance; DINAMO) Chronic kidney disease (CKD) Cardiovascular System , Nephrology 2022 View  |  Download
Enzalutamide for treating non-metastatic prostate cancer after radical prostatectomy and/or radiotherapy Enzalutamide (Xtandi; MDV3100) Non-metastatic prostate cancer Male Reproductive Cancer 2022 View  |  Download
Etrasimod for treating moderately to severely active ulcerative colitis Etrasimod (ADP334) Ulcerative colitis Gastroenterology 2022 View  |  Download
Fezolinetant for treating vasomotor symptoms associated with menopause Fezolinetant (ASP26963; ESN364) Post-menopausal vasomotor symptoms Women's Health 2022 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications